UnitedHealth Group (NYSE:UNH) PT Lowered to $650.00

UnitedHealth Group (NYSE:UNH) had its target price lowered by stock analysts at Bank of America from $675.00 to $650.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the healthcare conglomerate’s stock. Bank of America‘s price objective points to a potential upside of 14.84% from the stock’s current price.

Several other research firms have also recently commented on UNH. Barclays boosted their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Tuesday, October 1st. UBS Group raised their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday. Finally, HSBC increased their price objective on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $615.16.

UnitedHealth Group Stock Down 0.9 %

Shares of NYSE:UNH opened at $566.00 on Wednesday. The company has a 50 day moving average price of $584.20 and a two-hundred day moving average price of $533.07. The company has a market capitalization of $522.66 billion, a PE ratio of 37.53, a PEG ratio of 1.69 and a beta of 0.58. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the company earned $6.56 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group will post 27.68 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Beese Fulmer Investment Management Inc. grew its position in UnitedHealth Group by 1,262.2% during the first quarter. Beese Fulmer Investment Management Inc. now owns 20,623 shares of the healthcare conglomerate’s stock worth $10,202,000 after buying an additional 19,109 shares in the last quarter. Marion Wealth Management raised its stake in UnitedHealth Group by 1.8% in the first quarter. Marion Wealth Management now owns 4,733 shares of the healthcare conglomerate’s stock valued at $2,341,000 after purchasing an additional 82 shares in the last quarter. Atlas Brown Inc. grew its stake in UnitedHealth Group by 1.4% during the first quarter. Atlas Brown Inc. now owns 1,682 shares of the healthcare conglomerate’s stock worth $832,000 after buying an additional 24 shares in the last quarter. Emprise Bank acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $1,908,000. Finally, Rise Advisors LLC boosted its position in shares of UnitedHealth Group by 225.8% during the 1st quarter. Rise Advisors LLC now owns 694 shares of the healthcare conglomerate’s stock worth $344,000 after acquiring an additional 481 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.